Company: OXLCZ
Filing Date: 2025-02-19
Form Type: 424B2
Source: 0001213900-25-015045
Chunk: 11

Company: Oxford Lane Capital Corp.
Filing Date: 2025-02-19
Form: 424B2
Chunk 11
---
 environment, and we expect that the majority of our portfolio holdings, over the near to intermediate -term, will continue to be comprised of CLO debt and equity securities, with the more significant focus over the near -termlikely to be on CLO equity securities. Leverage by the Company We may use leverage as and to the extent permitted by the 1940 Act. We are permitted to obtain leverage using any form of financial leverage instruments, including funds borrowed from banks or other financial institutions, margin facilities, notes or preferred stock and leverage attributable to reverse repurchase agreements or similar transactions. Instruments that create leverage are generally considered to be senior securities under the 1940 Act. Under the 1940 Act, we are only permitted to incur additional indebtedness to the extent our asset coverage, as defined under the 1940 Act, is at least 300% immediately after each such borrowing. With respect to our outstanding preferred stock, we will generally be required to meet an asset coverage ratio, as defined under the 1940 Act, of at least 200% immediately after each issuance of such preferred stock. If we do not meet these asset coverage requirements, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness or redeem outstanding shares of preferred stock, in each case at a time when doing so may be disadvantageous. See “Regulation as a Registered Closed -EndManagement Investment Company” in the accompanying prospectus. Preferred Stock Our Board of Directors may classify any unissued shares of stock and reclassify any previously classified but unissued shares of stock of any class or series from time to time, in one or more classes or series of stock, including preferred stock. We have authorized 50 million shares of mandatorily redeemable preferred stock, at a par value of $0.01 per share, and had 8,761,706shares issued and outstanding at December 31, 2024. As of December 31, 2024, we had the following series of preferred stock outstanding: 6.25% Series 2027 Term Preferred Shares S-4 (the“Series 2027 Term Preferred Shares”), 6.00% Series 2029 Term Preferred Shares (the “6.00% Series 2029 Term Preferred Shares”), 7.125% Series 2029 Term Preferred Shares (the “7.125% Series 2029 Term Preferred Shares” and, together with the Series 2027